Skip to content
Open access

Hospital Mortality Considering Comorbidity and Patient Age Across Successive Epidemic Waves: A Descriptive Study

Oct 2026 · Kazan medical journal · 0 citations · 8 references

Abstract

Background

Comorbidity increases the risk of adverse outcomes in COVID-19; therefore, a systematic assessment of the pattern of concomitant diseases and the demographic characteristics of deceased patients is necessary for subsequent risk stratification and justifying patient triage in a hospital setting.

Aim

To analyze the association of comorbid pathology with in-hospital mortality in patients with COVID-19 based on the assessment of the pattern of concomitant diseases and the age of patients who died in the hospital.

Methods

A descriptive study (case series) of in-hospital deaths among patients with COVID-19 was conducted at the Republican Clinical Hospital named after Prof. A.F. Agafonov, Ministry of Health of the Republic of Tatarstan, in 2020–2022. Deaths among patients aged ≥18 years with confirmed COVID-19 were included if the minimally necessary data were available: age, sex, year of death, and concomitant diagnoses coded in accordance with the International Classification of Diseases, 10th Revision. Age- and sex-related characteristics, the distribution of deaths by year, and the frequency of concomitant conditions coded according to the International Classification of Diseases, 10th Revision (0, absence; 1, presence) were assessed, with acute complications analyzed separately. Descriptive statistics were used (median [Me], interquartile range [Q1–Q3], proportions with 95% CIs), as well as between-group comparisons (χ² or Fisher exact test), with p 0.05 considered statistically significant.

Results

The maximum proportion of deaths was registered among patients aged 60–74 years (42.6%), which allows this group to be considered the “core” of in-hospital mortality. Among the deceased, women predominated (62.3%), and their proportion increased in older groups (p = 5.22 × 10⁻⁵). The temporal structure of deaths was characterized by their concentration in 2021 (84.3%) compared with 2020 (10.4%) and 2022 (5.3%). The comorbidity profile was predominantly represented by chronic non-infectious diseases: arterial hypertension (81.7%), chronic heart failure (58.4%), chronic ischemic heart disease (33.1%), conduction disorders (12.3%), and atrial fibrillation/flutter (11.7%); type 2 diabetes mellitus (35.9%), obesity (29.0%), chronic kidney disease (20.4%), and anemia (17.5%).

Conclusion

In-hospital mortality in COVID-19 was predominantly formed among older patients with severe comorbidity; age and sex must be taken into account in subsequent multifactorial models and in the development of recommendations for risk stratification and patient triage.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.